Rohto Pharmaceutical Co., Ltd.
Important Dates
Rohto Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.
| Earnings Date | 11/12/2026 |
Share Statistics
As of March 31, 2026, Rohto Pharmaceutical Co., Ltd. has 225.96M shares outstanding.
| Shares Outstanding | 225.96M |
Financial Position
As of March 31, 2026, Rohto Pharmaceutical Co., Ltd. maintains a current ratio of 2.04, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.04 |
| Quick Ratio | 0.74 |
| Debt / Equity | 18.82 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 9,181.00 |
Balance Sheet
EURAs of March 31, 2026, Rohto Pharmaceutical Co., Ltd. holds 473.30M in cash and equivalents against 328.43M in total debt, resulting in a net debt position of -184.74M. Total book value stands at 1.65B, with working capital of 664.70M providing operational flexibility.
| Cash & Cash Equivalents | 473.30M |
| Total Debt | 328.43M |
| Net Debt | -184.74M |
| Equity (Book Value) | 1.65B |
| Book Value Per Share | 7.28 |
| Working Capital | 664.70M |
Stock Splits
Rohto Pharmaceutical Co., Ltd.'s most recent stock split took place on December 29, 2022 with a 1:2 split ratio.
| Last Split Date | 12/29/2022 |
| Split Ratio | 1:2 |